Medicamen Biotech gains on acquiring factory land in Q2FY18

10 Nov 2017 Evaluate

Medicamen Biotech is currently trading at Rs. 637.90, up by 5.70 points or 0.90% from its previous closing of Rs. 632.20 on the BSE.

The scrip opened at Rs. 649.85 and has touched a high and low of Rs. 649.85 and Rs. 615.00 respectively. So far 15696 shares were traded on the counter.

The BSE group 'XC' stock of face value Rs. 10 has touched a 52 week high of Rs. 677.00 on 07-Nov-2017 and a 52 week low of Rs. 198.70 on 24-Nov-2016.

Last one week high and low of the scrip stood at Rs. 677.00 and Rs. 600.00 respectively. The current market cap of the company is Rs. 714.41 crore.

The promoters holding in the company stood at 46.87%, while Institutions and Non-Institutions held 0.52% and 52.61% respectively.

Medicamen Biotech has acquired factory land (build up area of 35000 sq ft) adjoining to the existing manufacturing unit at Haridwar for future expansion during July-September 2017 quarter (Q2 FY18)

Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.

Medicamen Biotech Share Price

381.90 -8.35 (-2.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×